Investigation of siRNA-Loaded Polyethylenimine-Coated Human Serum Albumin Nanoparticle Complexes for the Treatment of Breast Cancer

Cell Biochemistry and Biophysics

Volumn 61, Issue 2, 2011, Pages 277-287

  Abbasi, Sana ^a   Paul, Arghya ^a   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Albumin; Breast cancer; Gene silencing; Nanobiotechnology; Nanomedicine; Nanoparticles

Indexed keywords

DRUG CARRIER; NANOPARTICLE; POLYETHYLENEIMINE; RIBONUCLEASE; SERUM ALBUMIN; SMALL INTERFERING RNA;

ARTICLE; BREAST TUMOR; CELL DEATH; CHEMISTRY; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOLECULAR WEIGHT; PATHOLOGY; PH; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; DRUG CARRIERS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR WEIGHT; NANOPARTICLES; POLYETHYLENEIMINE; RIBONUCLEASES; RNA, SMALL INTERFERING; SERUM ALBUMIN; TRANSFECTION;

EID: 80955166079     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9201-9     Document Type: Article

References (35)

1. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., et al. (2008). Cancer statistics, 2008. CA: A Cancer Journal for Clinicians, 58(2), 71-96.
2. Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010). Cancer Statistics, 2010. CA: A Cancer Journal for Clinicians, 60(5), 277-300.
3. Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. O., et al. (2006). RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system. Molecular Therapy, 14(4), 476-484.
4. Liu, X., Howard, K. A., Dong, M., Andersen, M. Ø., Rahbek, U. L., Johnsen, M. G., et al. (2007). The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials, 28(6), 1280-1288.
5. Schiffelers, R. M., Ansari, A., Xu, J., Zhou, Q., Tang, Q., Storm, G., et al. (2004). Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Research, 32(19), e149.
6. Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. (2004). RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Therapy, 12(5), 461-466.
7. Patil, Y., & Panyam, J. (2009). Polymeric nanoparticles for siRNA delivery and gene silencing. International Journal of Pharmaceutics, 367(1-2), 195-203.
8. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411(6836), 494-498.
9. Bumcrot, D., Manoharan, M., Koteliansky, V., & Sah, D. W. Y. (2006). RNAi therapeutics: a potential new class of pharmaceutical drugs. Nature Chemical Biology, 2(12), 711-719.
10. Ozpolat, B., Sood, A. K., & Lopez-Berestein, G. (2010). Nanomedicine based approaches for the delivery of siRNA in cancer. Journal of Internal Medicine, 267(1), 44-53.
11. Zhang, S., Zhao, B., Jiang, H., Wang, B., & Ma, B. (2007). Cationic lipids and polymers mediated vectors for delivery of siRNA. Journal of Controlled Release, 123(1), 1-10.
12. Hans, M. L., & Lowman, A. M. (2002). Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State and Materials Science, 6(4), 319-327.
13. Templeton, N., & Lasic, D. (1999). New directions in liposome gene delivery. Molecular Biotechnology, 11(2), 175-180.
14. Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008). Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. European Journal of Pharmaceutics and Biopharmaceutics, 69(1), 1-9.
15. Panyam, J., & Labhasetwar, V. (2003). Dynamics of endocytosis and exocytosis of poly(d, l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharmaceutical Research, 20(2), 212-220.
16. Kratz, F. (2008). Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. Journal of Controlled Release, 132(3), 171-183.
17. Wang, G., Siggers, K., Zhang, S., Jiang, H., Xu, Z., Zernicke, R., et al. (2008). Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharmaceutical Research, 25(12), 2896-2909.
18. Lü, J. M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., et al. (2009). Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Review of Molecular Diagnostics, 9(4), 325-341.
19. Liu, Y., Miyoshi, H., & Nakamura, M. (2007). Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. International Journal of Cancer, 120(12), 2527-2537.
20. Lin, W., Coombes, A. G. A., Davies, M. C., Davis, S. S., & Illum, L. (1993). Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. Journal of Drug Targeting, 1(3), 237-243.
21. Langer, K., Balthasar, S., Vogel, V., Dinauer, N., von Briesen, H., & Schubert, D. (2003). Optimization of the preparation process for human serum albumin (HSA) nanoparticles. International Journal of Pharmaceutics, 257(1-2), 169-180.
22. Douglas, J. (2007). Adenoviral vectors for gene therapy. Molecular Biotechnology, 36(1), 71-80.
23. Vorburger, S. A., & Hunt, K. K. (2002). Adenoviral gene therapy. The Oncologist, 7(1), 46-59.
24. Paul, A., Jardin, B., Kulamarva, A., Malhotra, M., Elias, C., & Prakash, S. (2010). Recombinant baculovirus as a highly potent vector for gene therapy of human colorectal carcinoma: molecular cloning, expression, and in vitro characterization. Molecular Biotechnology, 45(2), 129-139.
25. Wartlick, H., Spnkuch-Schmitt, B., Strebhardt, K., Kreuter, J. R., & Langer, K. (2004). Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles. Journal of Controlled Release, 96(3), 483-495.
26. Arshady, R. (1990). Albumin microspheres and microcapsules: methodology of manufacturing techniques. Journal of Controlled Release, 14(2), 111-131.
27. Leo, E., Angela Vandelli, M., Cameroni, R., & Forni, F. (1997). Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process. International Journal of Pharmaceutics, 155(1), 75-82.
28. Segura, S., Espuelas, S., Renedo, M. J., & Irache, J. M. (2005). Potential of albumin nanoparticles as carriers for interferon gamma. Drug Development and Industrial Pharmacy, 31(3), 271-280.
29. Zhang, S., Wang, G., Lin, X., Chatzinikolaidou, M., Jennissen, H. P., Laub, M., et al. (2008). Polyethylenimine-coated albumin nanoparticles for BMP-2 delivery. Biotechnology Progress, 24(4), 945-956.
30. Rhaese, S., von Briesen, H., Rübsamen-Waigmann, H., Kreuter, J., & Langer, K. (2003). Human serum albumin-polyethylenimine nanoparticles for gene delivery. Journal of Controlled Release, 92(1-2), 199-208.
31. Prabha, S., Zhou, W. Z., Panyam, J., & Labhasetwar, V. (2002). Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. International Journal of Pharmaceutics, 244(1-2), 105-115.
32. Yin Win, K., & Feng, S. S. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26(15), 2713-2722.
33. Helander, I. M., Alakomi, H. L., Latva-Kala, K., & Koski, P. (1997). Polyethyleneimine is an effective permeabilizer of Gram-negative bacteria. Microbiology, 143(10), 3193-3199.
34. Zauner, W., Farrow, N. A., & Haines, A. M. R. (2001). In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. Journal of Controlled Release, 71(1), 39-51.
35. Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997). The mechanism of uptake of biodegradable microparticles in caco-2 cells is size dependent. Pharmaceutical Research, 14(11), 1568-1573.